Jupiter Neurosciences (JUNS) Current Assets (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Current Assets of $4.8 million for Q4 2025, up 3.76% year-over-year from $4.7 million in Q4 2024, and up 195.58% quarter-over-quarter from $1.6 million in Q3 2025.
Jupiter Neurosciences (JUNS) Current Assets (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Current Assets for 3 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets rose 3.76% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (up 3.76% YoY), while the FY2025 annual figure was $4.8 million, up 3.76% from the prior year.
- Current Assets rose to $4.8 million in Q4 2025 per JUNS's latest filing, from $1.6 million in the prior quarter.
- Across five years, Current Assets topped out at $4.8 million in Q4 2025 and bottomed at $514.0 in Q3 2024.
- Historically, Current Assets has averaged $2.5 million across 3 years, with a median of $2.8 million in 2025.
- On a YoY basis, Current Assets climbed as much as 317479.38% in 2025 and fell as far as 3.76% in 2025.
- Jupiter Neurosciences' Current Assets stood at $28739.0 in 2023, then jumped by 16081.02% to $4.7 million in 2024, then gained by 3.76% to $4.8 million in 2025.
- Business Quant data shows JUNS's Current Assets at $4.8 million in Q4 2025, $1.6 million in Q3 2025, and $2.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 4.65 Mn |
| Sep 30, 2024 | 514.00 |
| Dec 31, 2023 | 28,739.00 |